Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 39
  • 0 comments

FDA approve OLMESARTAN MEDOXOMIL

Comment Full text

MYLAN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 31
  • 0 comments

FDA approve ALMOTRIPTAN MALATE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 44
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

SUNSHINE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 37
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 46
  • 0 comments

FDA approve RANOLAZINE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 50
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

STIRA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 49
  • 0 comments

FDA approve ZINC CHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 34
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text

RISING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 31
  • 0 comments

FDA approve MEMANTINE HYDROCHLORIDE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 47
  • 0 comments

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text
  • Previous
  • 135
  • 136
  • 137
  • 138
  • 139
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118334)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin